Brant Point Investment Management’s Pediatrix Medical MD Stock Holding History

Brant Point Investment Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-54,007	Closed	-$775K	–	140
2025 Q2	$775K	Sell	54,007 -320	-0.6%	-$4.39K	0.08%	107
2025 Q1	$787K	Sell	54,327 -17,363	-24%	-$247K	0.09%	121
2024 Q4	$941K	Buy	+71,690	New	+$990K	0.12%	115
2015 Q3	–	Sell	-15,000	Closed	-$1.11M	–	134
2015 Q2	$1.11M	Hold	15,000	–	–	0.1%	132
2015 Q1	$1.09M	Sell	15,000 -25,900	-63%	-$1.8M	0.1%	124
2014 Q4	$2.7M	Sell	40,900 -8,500	-17%	-$519K	0.25%	97
2014 Q3	$2.71M	Sell	49,400 -61,100	-55%	-$3.47M	0.26%	94
2014 Q2	$6.43M	Sell	110,500 -18,000	-14%	-$1.06M	0.58%	47
2014 Q1	$7.96M	Sell	128,500 -35,400	-22%	-$2.06M	0.76%	38
2013 Q4	$8.75M	Sell	163,900 -48,100	-23%	-$2.58M	0.8%	36
2013 Q3	$10.6M	Sell	212,000 -38,000	-15%	-$1.85M	1.21%	22
2013 Q2	$11.4M	Buy	+250,000	New	+$11.2M	1.24%	17

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Brant Point Investment Management's MD Position: Q3 2025 in Review

Brant Point Investment Management sold out of Pediatrix Medical (MD) in Q3 2025, closing a stake of 54,007 shares — an estimated $775K sold.

Brant Point Investment Management first reported a position in MD in Q2 2013 and held it in 12 quarters. The position peaked at $11.4M in Q2 2013. 268 funds tracked by Wall St. Rank hold MD as of Q3 2025.

Brant Point Investment Management reported no remaining Pediatrix Medical position as of Q3 2025 after selling out during the quarter.
Brant Point Investment Management sold 54,007 Pediatrix Medical shares in Q3 2025, an estimated $775K.
Brant Point Investment Management first reported a position in Pediatrix Medical in Q2 2013 and held it in 12 quarters.
Brant Point Investment Management's Pediatrix Medical position peaked at $11.4M in Q2 2013.
268 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2025.

Based on Brant Point Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.